Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9149)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 7, 2021 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cunha Júnior AD, Bragagnoli AC, Costa FO, Carvalheira JBC. Repurposing metformin for the treatment of gastrointestinal cancer. World J Gastroenterol 2021; 27(17): 1883-1904 [PMID: 34007128 DOI: 10.3748/wjg.v27.i17.1883] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i17/1883.htm |
| Number | Citing Articles |
| 1 |
Maria Zachou, Pagona Flevari, Narjes Nasiri-Ansari, Constantinos Varytimiadis, Evangelos Kalaitzakis, Eva Kassi, Theodoros Androutsakos. The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review. European Journal of Clinical Pharmacology 2024; 80(1): 127 doi: 10.1007/s00228-023-03586-1
|
| 2 |
Pedro Barrios-Bernal, Zyanya Lucia Zatarain-Barrón, Norma Hernández-Pedro, Mario Orozco-Morales, Alejandra Olivera-Ramírez, Federico Ávila-Moreno, Ana Laura Colín-González, Andrés F. Cardona, Rafael Rosell, Oscar Arrieta. Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses. Pharmaceuticals 2022; 15(7): 786 doi: 10.3390/ph15070786
|
| 3 |
Mohamad Ali Hijazi, André Gessner, Nahed El-Najjar. Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp. Cancers 2023; 15(12): 3199 doi: 10.3390/cancers15123199
|
| 4 |
Taqwa Al-Kofahi, Bahaa Altrad, Haneen Amawi, Alaa A Aljabali, Yousef M Abul-Haija, Mohammad A Obeid. Paclitaxel-Loaded Niosomes in Combination with Metformin: Development, Characterization and Anticancer Potentials. Therapeutic Delivery 2024; 15(2): 109 doi: 10.4155/tde-2023-0089
|
| 5 |
Sagarika Saha, Sanket Bapat, Durairaj Vijayasarathi, Renu Vyas. Exploring potential biomarkers and lead molecules in gastric cancer by network biology, drug repurposing and virtual screening strategies. Molecular Diversity 2024; doi: 10.1007/s11030-024-10995-6
|
| 6 |
Ling Zhang, Qijun Sun, Yuejian Ou, Qing Zhang, Ji'an Hu. Metformin Induces Cytotoxicity in Oral Squamous Cell Carcinoma Cells by Targeting CCN1/Akt-Axis. International Journal of Pharmacology 2022; 18(1): 182 doi: 10.3923/ijp.2022.182.189
|
| 7 |
Xiuying Kuang, Zhihui Liu. Mining the Biomarkers and Associated-Drugs for Esophageal Squamous Cell Carcinoma by Bioinformatic Methods. The Tohoku Journal of Experimental Medicine 2022; 256(1): 27 doi: 10.1620/tjem.256.27
|
| 8 |
Jiaxin Wang, Jie Lin, Huaijuan Guo, Wenjuan Wu, Jingjing Yang, Jingxian Mao, Wenbin Fan, Hong Qiao, Ying Wang, Xuebing Yan, Hong Guo. Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1419498
|
| 9 |
Talal El Zarif, Marcel Yibirin, Diana De Oliveira-Gomes, Marc Machaalani, Rashad Nawfal, Gianfranco Bittar, Hisham F. Bahmad, Nizar Bitar. Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing. Cancers 2022; 14(9): 2105 doi: 10.3390/cancers14092105
|
| 10 |
Dongyue Wang, Jingchen Wang, Yingying Cui. Tandem mass tag-based quantitative proteomic analysis of metformin’s inhibitory effects on ovarian cancer cells. Journal of Cancer Research and Therapeutics 2024; 20(4): 1293 doi: 10.4103/jcrt.jcrt_2449_23
|
| 11 |
Pınar KÖROĞLU. Prostat kanseri modelinde metformin ve matriks metalloproteinaz ilişkisine doğrudan bir köprü: oksidatif stress. Cukurova Medical Journal 2022; 47(1): 360 doi: 10.17826/cumj.1034451
|
| 12 |
Qian Wang, Xudong Wei. Research Progress on the Use of Metformin in Leukemia Treatment. Current Treatment Options in Oncology 2024; 25(2): 220 doi: 10.1007/s11864-024-01179-3
|
| 13 |
Jin-Soo Kim, Mi Young Kim, Sungyoul Hong. Synergistic Effects of Metformin and Trastuzumab on HER2 Positive Gastroesophageal Adenocarcinoma Cells In Vitro and In Vivo. Cancers 2023; 15(19): 4768 doi: 10.3390/cancers15194768
|
| 14 |
Min Hu, Yan Chen, Tao Ma, Li Jing. Repurposing Metformin in hematologic tumor: State of art. Current Problems in Cancer 2023; 47(4): 100972 doi: 10.1016/j.currproblcancer.2023.100972
|
| 15 |
Junhui Wu, Ruotong Yang, Huan Yu, Xueying Qin, Tao Wu, Yiqun Wu, Yonghua Hu. Association of Metformin Use with Iron Deficiency Anemia in Urban Chinese Patients with Type 2 Diabetes. Nutrients 2023; 15(14): 3081 doi: 10.3390/nu15143081
|
| 16 |
Sohini Samaddar, Daniel Buckles, Souvik Saha, Qiuyang Zhang, Ajay Bansal. Translating Molecular Biology Discoveries to Develop Targeted Cancer Interception in Barrett’s Esophagus. International Journal of Molecular Sciences 2023; 24(14): 11318 doi: 10.3390/ijms241411318
|
| 17 |
Srijita Sen, Hemant Kushwah, Om Prakash Ranjan. Drug Repurposing. 2024; : 57 doi: 10.1007/978-981-97-5016-0_5
|
| 18 |
Lingna Li, Jianing Huang, Tongmin Huang, Jie Yao, Yeyuan Zhang, Meiling Chen, Haojie Shentu, Haiying Lou, Flavia Prodam. Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies. International Journal of Endocrinology 2023; 2023: 1 doi: 10.1155/2023/5892731
|
| 19 |
I. V. Druk, E. A. Lyalyukova, E. A. Fadeeva. Metformin in the prevention of colorectal cancer with diabetes mellitus. Experimental and Clinical Gastroenterology 2022; (9): 161 doi: 10.31146/1682-8658-ecg-205-9-161-170
|
| 20 |
Rui Han, Jianghua Li, Yubo Wang, Tingting He, Jie Zheng, Yong He. Low BMI patients with advanced EGFR mutation-positive NSCLC can get a better outcome from metformin plus EGFR-TKI as first-line therapy: A secondary analysis of a phase 2 randomized clinical trial. Chinese Medical Journal Pulmonary and Critical Care Medicine 2023; 1(2): 119 doi: 10.1016/j.pccm.2023.04.006
|
| 21 |
Guo Chen. Will AMPK be a potential therapeutic target for hepatocellular carcinoma?. American Journal of Cancer Research 2024; 14(7): 3241 doi: 10.62347/YAVK1315
|
| 22 |
Katia Vázquez‑Ibarra, Josefina Sánchez López, Tomás Pineda Razo, José Cruz Lozano, Brenda Ortiz‑Tamayo, Luis Palafox‑Mariscal, Rosa González Arreola, Juan González‑García, Pablo Ortiz-Lazareno. Metformin in combination with chemotherapy increases apoptosis in gastric cancer cells and counteracts senescence induced by chemotherapy. Oncology Letters 2024; 28(4) doi: 10.3892/ol.2024.14590
|
| 23 |
Yixiong Chen, Lufang Wang, Na Chen, Guiju Tang. Metformin induces tumor immunogenic cell death in ovarian cancer by activating AMPK pathway. Translational Oncology 2024; 47: 102052 doi: 10.1016/j.tranon.2024.102052
|
| 24 |
Achiles Queiroz Monteiro de REZENDE, Everton CAZZO. NON-ALCOHOLIC FATTY LIVER DISEASE AND EXTRA-HEPATIC CANCER: A NARRATIVE REVIEW. Arquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612023-027
|
| 25 |
Wenhui Zhang, Li Zhou, Siyuan Qin, Jingwen Jiang, Zhao Huang, Zhe Zhang, Xiyu Zhang, Zheng Shi, Jie Lin. Sertaconazole provokes proapoptotic autophagy via stabilizing TRADD in nonsmall cell lung cancer cells. MedComm 2021; 2(4): 821 doi: 10.1002/mco2.102
|
| 26 |
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, Mohammad Reza Zali, Vahid Chaleshi, Andrea Riccio, Ehsan Nazemalhosseini-Mojarad, Mehdi Totonchi. Current trends and future prospects of drug repositioning in gastrointestinal oncology. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1329244
|
| 27 |
Neha Shree Maurya, Ashutosh Mani. Navigating Molecular Pathways: An Update on Drugs in Colorectal
Cancer Treatment. Current Topics in Medicinal Chemistry 2023; 23(30): 2821 doi: 10.2174/1568026623666230614165548
|
| 28 |
Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, Jorge Sastre-Serra, Daniel Gabriel Pons, Adamo Valle, Pilar Roca, Mercedes Nadal-Serrano. Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies. Biology 2024; 13(5): 302 doi: 10.3390/biology13050302
|
| 29 |
Junwei Wang, Siyi Lu, Yan Meng, Wei Fu, Xin Zhou. Beta adrenergic blockade and clinical outcomes in patients with colorectal cancer: A systematic review and meta-analysis. European Journal of Pharmacology 2022; 929: 175135 doi: 10.1016/j.ejphar.2022.175135
|
| 30 |
Michael A. Cahill. Quo vadis PGRMC? Grand-Scale Biology in Human Health and Disease. Frontiers in Bioscience-Landmark 2022; 27(11) doi: 10.31083/j.fbl2711318
|